Michael York Metacrine, Inc. (MTCR) insider trading activity

MTCR Quotes by TradingView

Michael York is Chief Business Officer of Metacrine, Inc.. Currently has a direct ownership of 103,499 shares of MTCR, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2023, when has been sold 107,054 shares (Common Stock) at a price of $0.41 per share, resulting in proceeds of $43,892. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K
0% 3M change
0% 12M change
Total Value Held $0

Michael York Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2023
SELL
Open market or private sale
$43,892 $0.41 p/Share
107,054 Reduced 50.84%
103,499 Common Stock
Feb 27 2022
BUY
Grant, award, or other acquisition
-
210,553 Added 50.0%
210,553 Common Stock

Also insider at

PHAS
PhaseBio Pharmaceuticals Inc Healthcare
VP, Corporate Development
MY

Michael York

Chief Business Officer
Malvern, PA

Track Institutional and Insider Activities on MTCR

Follow Metacrine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTCR shares.

Notify only if

Insider Trading

Get notified when an Metacrine, Inc. insider buys or sells MTCR shares.

Notify only if

News

Receive news related to Metacrine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTCR